Edge Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency
Jun 08, 2017 10:30 am UTC| Business
BERKELEY HEIGHTS, N.J., June 08, 2017 -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of acute, life-threatening conditions,...
Jun 08, 2017 10:30 am UTC| Business
MISSISSAUGA, Ontario, June 08, 2017 -- Hydrogenics Corporation (NASDAQ:HYGS) (TSX:HYG) (the “Company” or “Hydrogenics”), a leading developer and manufacturer of hydrogen generation and hydrogen-based power modules,...
New Impact Investing Report Highlights Mosaic’s Commitment to Employee Ownership
Jun 08, 2017 10:15 am UTC| Business
CHARLOTTE, N.C., June 08, 2017 -- With income inequality in the United States at record high levels, employee ownership is increasingly being lauded as a potential solution to spreading wealth more broadly. Most...
VivoPower International PLC Reports Results for the Year Ended March 31, 2017
Jun 08, 2017 10:02 am UTC| Business
Statutory Net Income of $5.6 million and Adjusted Net Income of $12.3 millionAdjusted EBITDA of $18.9 million, exceeding prior upgraded forecast of $18.8 million and initial forecast of $18.0 millionEPS of $0.73 and...
Jun 08, 2017 10:00 am UTC| Business
SAN FRANCISCO, June 08, 2017 -- JadooTV Inc. announced today the launch of its fifth generation IPTV set-top box, Jadoo5™. The newest box combines the latest technology - 4K UHD, H.265 High Efficiency Video Coding Quad...
Bridge Bank and ORIX Growth Capital Finance Provide New Credit Facility to Revolution Foods
Jun 08, 2017 10:00 am UTC| Business
SAN JOSE, Calif., June 08, 2017 -- Bridge Bank and ORIX Growth Capital (“ORIX”) today announced that the firms have provided Revolution Foods with a revised accounts receivable line of credit facility from Bridge Bank...
Jun 08, 2017 10:00 am UTC| Business
PLYMOUTH MEETING, Pa., June 08, 2017 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that it has commenced its phase 3 clinical program to evaluate the efficacy of Inovio’s DNA-based immunotherapy,...